1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47296
Office O'Donoghue Research Bldg., 1122 NE 13th St., Ste. 4417, OKC 73117
Email jamie-miller@ouhsc.edu
Publications & Presentations
- 31. Miller J L. Neonatal Disease. Hunan Science and Technology Press. 2021 : 585-598
32. Lim S Y, Miller J L, Henry E, Heltsley R, Woo S, Johnson P N. Analysis of fentanyl pharmacokinetics, and its sedative effects and tolerance in critically ill children. Pharmacotherapy. 2021; 41 : 359-369
33. Lewis S L, Johnson J J, Bergner E M, Miller J L, Bruster C ', Atchley C B, Ernst K D. Infant Essential Fatty Acid Status Is Not Associated With Postoperative Wound Complication Severity. The Journal of surgical research. 2021; 258 : 435-442
34. Harkin M, Johnson P N, Neely S, White L, Miller J L. Frequency and Severity of Chlorothiazide-Induced Hyponatremia in the Neonatal Intensive Care Unit. American journal of perinatology. 2021
35. Weller B M, Shaddix B P, Oschman A, Johnson P N, Neely S, Chaaban H, Williams P K, Miller J L. A Pilot Evaluation of the Possible Association of Metronidazole With Neurodevelopmental Outcomes in Premature Neonates. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2021; 26 : 455-459
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 6. Pediatric Pharmacy Advocacy Group. Outstanding Original Research Award. Date: 2018.
7. Pediatric Pharmacy Advocacy Group. Scholarship in Teaching Award. Date: 2018.
8. Pediatric Pharmacy Advocacy Group. Christensen Memorial Young Investigator Award (Resident Mentor). Date: 2016.
9. Pediatric Pharmacy Advocacy Group. Outstanding Original Paper. Date: 2014.
Education
- 1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.
2. Degree: BS. Trevecca Nazarene University. Date: 2002.